In research literature, Epitalon is generally treated as a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a natural pineal gland extract, studied in telomerase activation and melatonin pathway assay models. Epitalon has been reported to activate telomerase (hTERT) transcription in somatic cell cultures, increasing telomerase enzyme activity and extending telomere length in serial passage experiments โ an area of active interest in cellular ageing research. Mechanistically, upregulation of hTERT expression may involve chromatin remodelling at the TERT promoter, with some studies implicating epigenetic changes. In pinealocyte assay models, epithalamin extracts (of which epitalon represents the characterised active fraction) modulate melatonin synthesis enzymes (AANAT and HIOMT), relevant to circadian biology research.
Telomere biology and telomerase regulation are areas where research tools are limited, making epitalon an unusual small peptide with a potentially useful role as a telomerase-activating perturbagen in comparative ageing-pathway studies. Its very short sequence (4 residues, MW โ 390 Da) simplifies analytical characterisation relative to larger research peptides. For laboratory teams, the practical emphasis is usually on sequence identity, receptor or pathway relevance where documented, and whether Epitalon behaves consistently across stability, purity, and analytical verification workflows. Variant labels on this page support clearer internal referencing when multiple labelled variants are under review.